Compare
Greenwich LifeSciences, Inc. vs Aethlon Medical Inc vs GeoVax Labs, Inc. vs Vyome Holdings, Inc
| Latest fiscal year | Greenwich LifeSciences, Inc. GLSI | Aethlon Medical Inc AEMD | GeoVax Labs, Inc. GOVX | Vyome Holdings, Inc HIND |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-03-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | n/a | $2.49M | $319.7K |
| Revenue growth (YoY) | n/a | n/a | -37.1% | +24.4% |
| Gross margin | n/a | n/a | n/a | 68.4% |
| Operating margin | n/a | n/a | -869.3% | n/m |
| Net margin | n/a | n/a | -862.3% | n/m |
| Net income | -$19.36M | -$7.15M | -$21.46M | -$10.26M |
| EPS (Diluted) | -$1.43 | -$10.61 | n/a | -$4.86 |
| Operating cash flow | -$9.91M | -$7.00M | -$21.47M | -$3.75M |
| Free cash flow | n/a | -$7.00M | -$21.50M | n/a |
| Cash & equivalents | $6.18M | $5.03M | $3.09M | $4.98M |
| Total assets | $6.18M | $6.33M | $6.34M | $6.50M |
| Total liabilities | $5.82M | $1.45M | $2.52M | $2.74M |
| Shareholders' equity | $353.2K | $4.89M | $3.83M | $3.76M |
| Return on year-end equity | n/m | -146.4% | -561.2% | -272.8% |
| Shares outstanding | 14.30M | 1.57M | 1.73M | 5.92M |
Revenue, most recent five fiscal years
| Fiscal year | Greenwich LifeSciences, Inc. | Aethlon Medical Inc | GeoVax Labs, Inc. | Vyome Holdings, Inc |
|---|---|---|---|---|
| Latest | n/a | $0 Ended 2024-03-31 | $2.49M Ended 2025-12-31 | $319.7K Ended 2025-12-31 |
| 1 year earlier | n/a | $574.2K Ended 2023-03-31 | $3.95M Ended 2024-12-31 | $256.9K Ended 2024-12-31 |
| 2 years earlier | n/a | $294.2K Ended 2022-03-31 | $0 Ended 2023-12-31 | $8.68M Ended 2023-12-31 |
| 3 years earlier | n/a | $659.1K Ended 2021-03-31 | $81.5K Ended 2022-12-31 | $11.24M Ended 2022-12-31 |
| 4 years earlier | n/a | $650.2K Ended 2020-03-31 | $385.5K Ended 2021-12-31 | $13.60M Ended 2021-12-31 |